Stay updated on Uproleselan with Chemotherapy for AML Clinical Trial

Sign up to get notified when there's something new on the Uproleselan with Chemotherapy for AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Uproleselan with Chemotherapy for AML Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    A sitewide NIH notice says that agency content may use “Super Intelligence” in place of “Artificial Intelligence” during a transition. It appears above the page’s 403 error message.
    Difference
    1%
    Check dated 2026-10-25T16:34:30.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The footer revision identifier updates from v3.7.1 to v3.7.2 while the study page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-18T22:28:26.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The footer now identifies the ClinicalTrials.gov site revision as v3.7.1 instead of v3.7.0.
    Difference
    0.2%
    Check dated 2026-10-11T22:26:31.000Z thumbnail image
  4. Check
    37 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error instead of the study content, indicating restricted access to the requested study record.
    Difference
    17%
    Check dated 2026-09-20T19:58:10.000Z thumbnail image
  5. Check
    58 days ago
    Change Detected
    Summary
    Page revision updated from v3.6.5 to v3.6.6; this represents a minor update to the page's metadata or display without changing study details.
    Difference
    0.0%
    Check dated 2026-08-30T21:57:52.000Z thumbnail image
  6. Check
    80 days ago
    Change Detected
    Summary
    Revision metadata on the page was updated from v3.6.4 to v3.6.5, reflecting a version upgrade. The change does not affect the study data or displayed information.
    Difference
    0.0%
    Check dated 2026-08-09T11:35:03.000Z thumbnail image

Stay in the know with updates to Uproleselan with Chemotherapy for AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Uproleselan with Chemotherapy for AML Clinical Trial page.